Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. - Wikidata - awgldk - TriplyDB

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

http://www.wikidata.org/entity/Q36293295

about

Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development.miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.Oncogenic signaling of MEK5-ERK5.Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 Activation.Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation.MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.

P2860

Q35836432-92942270-E5B4-411E-842A-7A45E81B6FE2 Q36962611-89245475-AB97-4D41-B063-24ED6D0722CD Q38814489-72630E39-3821-4A4A-981D-CF13A7B6CC59 Q39116456-6AE5BE61-5491-4795-AA92-91E54B37DC5E Q40159153-F90FEFA5-20CD-4748-9123-229730468E4A Q41033728-091C406C-EC22-4621-A5BA-70C45DA5B932 Q41610131-9C1D28EF-F20E-437E-AD9B-278ABC6623CC Q42051316-06C9D626-7B97-45A1-A007-FDF2487BB3DC Q51164416-68C7E8B7-17F8-453D-8B39-411EFFCCA62E

P2860

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

http://www.wikidata.org/entity/Q36293295

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@ast

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@en

type

label

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@ast

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@en

prefLabel

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@ast

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@en

P1433

Q36293295-BE712B23-FF93-4C5C-A64A-F9BA882393AD

P1476

Q36293295-4E07CCF7-294D-4442-ABAE-6A2B5CFE0695

P2093

Q36293295-36A233BD-88D8-4CFE-ABE4-139A8793F3AA

Q36293295-AFFF22C8-4F3E-437F-A9C1-85DE4A356395

Q36293295-D73F4C72-B078-40DB-A522-7FF2409DC734

P2860

Q36293295-0601E621-81C0-4B4C-AE1D-27EFD15507A3

Q36293295-0B7A5ED8-AD7D-49BF-8F9C-4E3DAD6ECB33

Q36293295-0D876221-6A87-418F-8089-44786442C9A5

Q36293295-0DA0589E-80CD-4A11-9A80-521100EABBB2

Q36293295-0FFACBD5-E351-4D81-B66F-52EBE9EBB0E4

Q36293295-10C51DC2-6F80-43BF-8D2C-3FE3379242F3

Q36293295-1E396DF4-0CA9-46AD-B056-DC06AE215C2B

Q36293295-20A69271-CB47-4A65-9D2E-4CC059BC2BE1

Q36293295-26BD6CAD-BE6C-4D02-8D22-8D9210B59580

Q36293295-274347A9-DE84-48A7-9F21-698EAD7F89D4

P2888

Q36293295-141FAC22-9C70-4039-94A9-3BE2256DE20A

P304

Q36293295-63F6D8E8-BE03-4FE4-8BEE-68AFED31E781

P31

Q36293295-ABDE0716-6751-46C9-80F9-6200B13C1D4F

P356

Q36293295-785D2FAA-3E71-4937-9847-0213301502C2

P478

Q36293295-F025C5BE-B42D-4B70-9AC1-435DB8C32D1A

P50

Q36293295-03066882-679B-41FA-BAD7-687802ED4981

Q36293295-06826B70-332F-4805-B369-9EEBAF09CF30

Q36293295-284B4C6E-DC8D-4701-B645-BD9AD1EF9923

Q36293295-309283C7-B422-4C33-8510-A7C024ED8368

Q36293295-422C1852-562D-4A23-A357-E157E99F8F94

Q36293295-54865232-1E8B-4B52-B19F-FBF6EE2525B6

Q36293295-6C9756E8-F6E0-4639-9DE8-531160B64BC5

Q36293295-7EBC38B1-B0C8-4A14-9025-159DBFA19E17

P577

Q36293295-52DB83EB-5302-4F33-BE8A-632EC4CC33A4

P5875

Q36293295-C7DF0DDD-18E9-4E91-9968-B72A8BC15112

P6179

Q36293295-29B8FA64-28E2-4E2A-9564-8C37F29CDBCD

P698

Q36293295-7251A56D-EC6C-4945-9E9A-E362A1F45F56

P921

Q36293295-7A0BD0BB-DFFB-45C2-A1F8-38DB18C6A166

P932

Q36293295-CCB57744-9ECF-4982-884C-3842DF543ABD

P356

P1433

Cell Death and Disease

P1476

Aberrant MEK5/ERK5 signalling ...... gression via NF-κB activation.

@en

P2093

A French

http://www.w3.org/2001/XMLSchema#string

C J Steer

http://www.w3.org/2001/XMLSchema#string

S N Thibodeau

http://www.w3.org/2001/XMLSchema#string

P2860

miRNA expression in colon polyps provides evidence for a multihit model of colon cancer

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray

Reduced accumulation of specific microRNAs in colorectal neoplasia

Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway

Nuclear factor-kappaB in cancer development and progression

miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

P2888

P304

e1718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2015.83

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Cecilia Rodrigues

Diane M. Pereira

Tânia Carvalho

Pedro M Borralho

André E S Simões

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274725206

http://www.w3.org/2001/XMLSchema#string

P6179

1037019618

http://www.w3.org/2001/XMLSchema#string

P698

25855966

http://www.w3.org/2001/XMLSchema#string

P921

P932

4650550

http://www.w3.org/2001/XMLSchema#string